The necessity of adjusting the dosage of zonisamide when coadministered with other anti-epileptic drugs

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 8, 1996, Pages 1090-1092

  Shinoda, Masahiko ^a   Akita, Masahiro ^a   Hasegawa, Masaya ^b   Hasegawa, Takaaki ^a   Nabeshima, Toshitaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

carbamazepine 10,11 epoxide carbamazepine ratio; drug interaction; plasma concentration dose ratio; valproic acid; zonisamide

Indexed keywords

CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; CLONAZEPAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; ZONISAMIDE;

ADOLESCENT; ADULT; ARTICLE; CHILD; DOSE CALCULATION; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG METABOLISM; DRUG MONITORING; DRUG SAFETY; EPILEPSY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; STEADY STATE;

EID: 0029779675     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.1090     Document Type: Article

References (22)

1. Ito T., Yamaguchi T., Miyazaki H., Sekine Y., Shimizu M., Ishida S., Yagi K., Kakegawa N., Seino M., Wada T., Arznein.-Forsch./Drug Res., 32, 1581-1586 (1982).
2. Mimaki T., Sugimoto T., Murata R., Nagai A., Mino M., TDM Kenkyu, 9, 49-55 (1992).
3. Horiuch T., Nakamura M., Sugiyama T., Katagiri Y., TDM Kenkyu, 12, 249-250 (1995).
4. Ojemann L. M., Shastri R. A., Wilensky A. J., Friel P. N., Levy R. H., Mclean J. R., Buchanan A., Ther. Drug Monit., 8, 293-296 (1986).
5. Kaneko S., Hayashimoto A., Niwayama H., Fukushima Y., Tenkan Kenkyu, 11, 31-35 (1993).
6. Ijiri Y., Ohi K., Suzuki K., Fukuoka E., Furuya T., Yoshinari S., Tamai H., Byoin Yakugaku, 20, 207-212 (1994).
7. Ono T., Yagi K., Seino M., Seishin Igaku, 30, 471-482 (1988).
8. Hashimoto Y., Odani A., Tanigawara Y., Yasuhara M., Okuno T., Hori R., Biol. Pharm. Bull., 17, 323-326 (1994).
9. Kimura M., Tanaka N., Kimura Y., Miyake K., Kitaura T., Fukuchi H., Harada Y., Chem. Pharm. Bull., 40, 193-195 (1992).
10. Fukushima K., Yagi Y., Seino M., Fujiwara T., Watanabe M., Muranaka H., Kudo T., Okabe M., Otani K., Terauchi N., Numata Y., Syonika Rinsyo, 40, 3389-3397 (1987).
11. Minami T., Ieiri I., Iida T., Ohtsubo K., Hirakawa Y., Ueda K., Higuchi S., Aoyama T., Epilepsia, 35, 1023-1025 (1994).
12. Shinoda M., Akita M., Hasegawa M., Hasegawa T., Nabeshima T., Byoin Yakugaku, 21, 185-190 (1995).
13. Shinoda M., Akita M., Johno I., Kitazawa S., Abstracts of Papers, The Annual Meeting of the Pharmaceutical Society of Japan, Sendai, March 1984, p. 752.
14. Stiff D. D., Robicheau J. T., Zemaitis M. A., Xenobiotica, 22, 1-11 (1992).
15. Nakasa H., Komiya M., Ohmori S., RikihisaT., Kiuchi M., Kitada M., Mol. Pharmacol, 44, 216-221 (1993).
16. Kimura M., Tanaka N., Kimura Y., Miyake K., Kitaura T., Fukuchi H., J. Pharmacobio-Dyn., 15, 631-639 (1992).
17. Konishi H., Morita K., Ono T., Shimakawa H., Yakuzaigaku, 50, 323-328 (1990).
18. Penry J. K., Newmark M. E., Ann. Intern Med., 90, 207-281 (1979).
19. Pugh C. B., Garnett W. R., Clin. Pharm., 10, 335-358 (1991).
20. Friel P. N., Leal K. W., Wilensky A. J., Ther. Drug Monit., 1, 243-248 (1979).
21. Perucca E., Hibdige S., Frigo G. M., Gatti G., Lecchini S., Crema A., Clin. Pharmacol. Ther., 28, 779-789 (1980).
22. Nishihara K., Sawada Y., Iga T., Chiryo, 76, 121-124 (1994).